Canada markets closed

Kyverna Therapeutics, Inc. (KYTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
7.50+0.14 (+1.90%)
At close: 04:00PM EDT
7.50 0.00 (0.00%)
After hours: 07:33PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
Total Revenue
0
0
7,025
5,656
Operating Expenses
Research Development
63,688
49,923
28,402
25,852
Selling General and Administrative
16,631
12,483
8,007
6,150
Total Operating Expenses
80,319
62,406
36,409
32,002
Operating Income or Loss
-80,319
-62,406
-29,384
-26,346
Interest Expense
187
187
65
3
Total Other Income/Expenses Net
-78
-55
-9
-2
Income Before Tax
-75,916
-60,366
-28,893
-26,350
Income from Continuing Operations
-75,916
-60,366
-28,893
-26,350
Net Income
-75,916
-60,366
-28,893
-26,350
Net Income available to common shareholders
-75,916
-60,366
-28,893
-26,350
Basic EPS
-1.18
-1.48
-1.12
-1.02
Diluted EPS
-1.18
-1.48
-1.12
-1.02
Basic Average Shares
40,823
40,823
25,804
25,804
Diluted Average Shares
40,823
40,823
25,804
25,804